Drug intelligence / Profile preview

l-carnitine tartrate

Development stage
Phase 4
Lead developer
Lonza
Modality
Small Molecules
Administration
Oral
01

Overview

L-carnitine tartrate is a dietary supplement form of L-carnitine combined with tartaric acid to enhance stability and absorption. It plays a critical role in energy metabolism by transporting long-chain fatty acids into the mitochondria for beta-oxidation and energy production. This process helps reduce purine catabolism and free radical formation, which may prevent exercise fatigue, muscle weakness, chemotherapy-induced peripheral neuropathy, and hyperlipoproteinemia[1][2][4]. Supplementation has been shown to improve recovery after exercise by reducing muscle soreness and biochemical markers of muscle damage[5]. It is primarily used to treat or prevent low blood levels of carnitine due to genetic disorders or other medical conditions but is also marketed for athletic performance enhancement and weight loss[2][8].

Brand names
CarnipureL-Carnitine Tartrate
Other names
L-carnitine L-tartratelevocarnitine tartratecarnitine tartrate
02

Targets

SLC22A5 (Organic cation/carnitine transporter 2)CPT2 (Carnitine O-palmitoyltransferase 2)SLC7A1 (Cationic amino acid transporter 1)SLC25A20 (Carnitine/acylcarnitine translocase)

Beyond the preview

Go deeper on l-carnitine tartrate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on l-carnitine tartrate.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call